BIOCRYST PHARMACEUTICALS INC
Biological Products, (No Diagnostic Substances) · 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
官方登記資料
0位追蹤者
1986成立於
關於 BIOCRYST PHARMACEUTICALS INC
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a commercial stage biotech company that focuses on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by the FDA in December 2014 and berotralstat (ORLADEYO) was approved in December 2020.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
成立時間1986
法律形式C Corporation
狀態營運中
專利16 項專利
ORAL COMPLEMENT FACTOR D INHIBITORSJP2025179186A · 2025
CRYSTALLINE SALTS OF PLASMA KALLIKREIN INHIBITORJP2024109860A · 2024
關鍵數據
法律資訊
| 法定名稱 | BIOCRYST PHARMACEUTICALS INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 882796在 SEC EDGAR 上查看 ↗ |
| EIN | 62-1413174 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面